The Impact of Germline Genetic Variations in Hydroxysteroid (17-Beta) Dehydrogenases on Prostate Cancer Outcomes After Prostatectomy Full Text
European Urology, 06/26/2012
Audet–Walsh E et al. – This study suggests a prominent role for common genetic variants in the HSD17B2 pathway in prostate cancer progression.



